RESUMO
The drug Amalaki (Emblica Officinalis Gaertn.) belongs to family Euphorbiaceae, is used since ancient time for therapeutic purposes. It has been used in the traditional Indian medicine of ‘Ayurveda’ for the treatment of a variety of diseases. Amalaki has five Rasa (taste) except Lavana (salt), It is mainly Amla Ras Pradhan. Its Vipaka (taste after digestion) is Madhura (sweet) and Veerya (potency) is Sheeta (cool). Because of these qualities, the plant performs various pharmacological actions such as anti-inflammatory activity, antioxidant activity, immunomodulatory activity, anti-tussive, antiulcer activity, anticancerous activity, anti-diarroheal and spasmolytic, antidiabetic, in reducing cholesterol and dyslipidemia, antimicrobial, anti-asthmatic. It helps to improve physical and mental health, prevents degeneration, extends youth and delays aging or rather reverse the aging process. Various parts of Amalaki has been described in morphology like root, stem, leaf, seed, flower and fruit. Synonyms and their interpretation, Vernacular names, Rasapanchaka and Karma of Amalaki in various Nighantus (Dhanwantri Nighantu, Shodhal Nighantu, Madanpal Nighantu, Bhavprakasha Nighantu, Kaiyadeva Nighantu and Raj Nighantu) has been described. Classical categorization of plant Amalaki in Charaka Samhita, Sushruta Samhita and Ashtanga Hridaya has been explained according to its Karma and this paper presented a comprehensive review of Emblica Officinalis Gaertn
RESUMO
During the last few years India has maximum increase of Type 2 diabetes mellitus. Type 2 diabetes is characterized by high blood sugar, insulin resistance, and relative lack of insulin. There are approximate 72.96 million cases of diabetes mellitus in adult population of India. In modern era single anti-diabetic drug is not sufficient for glucose control. These days multidrug therapy is building its popularity for maintaining glycaemic levels. A 59-year-old female presented with known case of Type 2 diabetes with evidence of polyuria, itching over extremities, and fatigue was poorly controlled despite a drug regimen consisting of oral metformin and glimepiride. Her Blood Sugar level was constantly around 200 mg/dl in spite of having modern medicine with adjusted doses. She has administered Nisha-Amalaki Churna with warm water early in the morning along with standard conventional treatment for 8 weeks. The effect of therapy was evaluated at the interval of 4 weeks for 8 weeks which is done on the basis of objective parameters. Objective parameters were fasting and post prandial Blood Sugar Level. Nisha-Amalaki churna has reduced Blood Sugar Level to normal. It also reduced the dose of conventional drug which may cause side effects with long term use. There is a need for combined multidisciplinary treatment to maintain suggested glycaemic control. Thus, the present case study is to understand the significant effect of Nisha-Amalaki as an adjuvant to standard conventional treatment in chronic uncontrolled type 2 Diabetes Mellitus.
RESUMO
Background: Systemic lupus erythematosus is a systemic auto immune connective tissue disease that can affect any part of the body. The disease has no direct reference in Ayurvedic texts. Considering the symptomatology, it can be compared with Upadrava of Vatarakta. Methodology: In this study, 3 patients (age group between 15– 60 yrs) diagnosed SLE with the help of ACR criteria after assessing both objective and subjective parameters have undergone the prescribed classical Ayurvedic treatments, in both IP and OP level to evaluate its effect in the functional improvement. The study period was totally 57 days which included 21 days each at inpatient and outpatient basis and 15 days of follow up. Initially Sathaila Shastika Pinda Sweda was done for first 7 days followed by Takradhara for another 7 days. Consecutively Abhyanga with Pinda taila and Thalam with Amalaki were done for next 7 days. Then treatment was done on OP basis with internal medicines. Result: Results shows that the prescribed Ayurvedic treatments helped to control the progressive signs and symptoms. The quality of life and range of movements of the affected joints improved. Major difference showing a good improvement in carrying out the day today life activities was noted. Conclusion: Traditional Ashtavaidyan Ayurveda therapy is found effective in controlling the progressive symptoms of patients and improvement in functional ability of the patients with SLE. More over there was no adverse drug reaction recorded during as well there was significant change observed in liver and renal function tests. This indicates that the therapy is safe without producing any complication or side effects.